151 related articles for article (PubMed ID: 32967007)
21. Genome-wide DNA methylation profiling identifies primary central nervous system lymphoma as a distinct entity different from systemic diffuse large B-cell lymphoma.
Nakamura T; Yamashita S; Fukumura K; Nakabayashi J; Tanaka K; Tamura K; Tateishi K; Kinoshita M; Fukushima S; Takami H; Fukuoka K; Yamazaki K; Matsushita Y; Ohno M; Miyakita Y; Shibui S; Kubo A; Shuto T; Kocialkowski S; Yamanaka S; Mukasa A; Sasayama T; Mishima K; Maehara T; Kawahara N; Nagane M; Narita Y; Mano H; Ushijima T; Ichimura K
Acta Neuropathol; 2017 Feb; 133(2):321-324. PubMed ID: 28058506
[No Abstract] [Full Text] [Related]
22. First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial.
Vitolo U; Chiappella A; Ferreri AJ; Martelli M; Baldi I; Balzarotti M; Bottelli C; Conconi A; Gomez H; Lopez-Guillermo A; Martinelli G; Merli F; Novero D; Orsucci L; Pavone V; Ricardi U; Storti S; Gospodarowicz MK; Cavalli F; Sarris AH; Zucca E
J Clin Oncol; 2011 Jul; 29(20):2766-72. PubMed ID: 21646602
[TBL] [Abstract][Full Text] [Related]
23. Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma.
Xu T; Jia Q; Wang Y; Liu Y; Han D; Li P; Ma J; Fan L; Yan Q; Guo S; Li M; Wang Z
Diagn Pathol; 2019 May; 14(1):45. PubMed ID: 31109360
[TBL] [Abstract][Full Text] [Related]
24. Gene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing Analyses.
Todorovic Balint M; Jelicic J; Mihaljevic B; Kostic J; Stanic B; Balint B; Pejanovic N; Lucic B; Tosic N; Marjanovic I; Stojiljkovic M; Karan-Djurasevic T; Perisic O; Rakocevic G; Popovic M; Raicevic S; Bila J; Antic D; Andjelic B; Pavlovic S
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27164089
[TBL] [Abstract][Full Text] [Related]
25. Central nervous system lymphoma newly developed 12 years after remission of an ocular adnexal lymphoma.
Morikawa K; Tsuji T; Yamasaki H; Toyozumi Y; Arima N; Ohshima K; Tsuda H
Acta Haematol; 2013; 130(4):247-50. PubMed ID: 23860499
[TBL] [Abstract][Full Text] [Related]
26. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens].
Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248
[No Abstract] [Full Text] [Related]
27. Frequent triple-hit expression of MYC, BCL2, and BCL6 in primary lymphoma of the central nervous system and absence of a favorable MYC(low)BCL2 (low) subgroup may underlie the inferior prognosis as compared to systemic diffuse large B cell lymphomas.
Brunn A; Nagel I; Montesinos-Rongen M; Klapper W; Vater I; Paulus W; Hans V; Blümcke I; Weis J; Siebert R; Deckert M
Acta Neuropathol; 2013 Oct; 126(4):603-5. PubMed ID: 24061549
[No Abstract] [Full Text] [Related]
28. Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways.
Booman M; Szuhai K; Rosenwald A; Hartmann E; Kluin-Nelemans H; de Jong D; Schuuring E; Kluin P
J Pathol; 2008 Oct; 216(2):209-17. PubMed ID: 18729069
[TBL] [Abstract][Full Text] [Related]
29. High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma.
Kraan W; van Keimpema M; Horlings HM; Schilder-Tol EJ; Oud ME; Noorduyn LA; Kluin PM; Kersten MJ; Spaargaren M; Pals ST
Leukemia; 2014 Mar; 28(3):719-20. PubMed ID: 24253023
[No Abstract] [Full Text] [Related]
30. Advances in risk assessment and prophylaxis for central nervous system relapse in diffuse large B-cell lymphoma.
Qualls D; Abramson JS
Haematologica; 2019 Jan; 104(1):25-34. PubMed ID: 30573511
[TBL] [Abstract][Full Text] [Related]
31. Contralateral testicular relapse after prophylactic radiation in a patient with primary testicular diffuse large B-cell lymphoma.
Conrad AL; Go RS
Eur J Haematol; 2009 Dec; 83(6):603-5. PubMed ID: 19682312
[TBL] [Abstract][Full Text] [Related]
32. Primary testicular lymphoma with central nervous system involvement.
Lands RH; Shoaf F; Karnad A
J Tenn Med Assoc; 1991 Jul; 84(7):327-8. PubMed ID: 1870344
[No Abstract] [Full Text] [Related]
33. [Primary central nervous system lymphoma: pathogenesis and histomorphology].
Méhes G
Magy Onkol; 2017 Mar; 61(1):81-87. PubMed ID: 28273192
[TBL] [Abstract][Full Text] [Related]
34. Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study.
Kim SJ; Hong JS; Chang MH; Kim JA; Kwak JY; Kim JS; Yoon DH; Lee WS; Do YR; Kang HJ; Eom HS; Park Y; Won JH; Mun YC; Kim HJ; Kwon JH; Kong JH; Oh SY; Lee S; Bae SH; Yang DH; Jun HJ; Kim YS; Yun HJ; Lee SI; Kim MK; Park EK; Kim WS; Suh C
Oncotarget; 2016 Nov; 7(44):72033-72043. PubMed ID: 27713132
[TBL] [Abstract][Full Text] [Related]
35. Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
Landsburg DJ; Petrich AM; Abramson JS; Sohani AR; Press O; Cassaday R; Chavez JC; Song K; Zelenetz AD; Gandhi M; Shah N; Fenske TS; Jaso J; Medeiros LJ; Yang DT; Nabhan C
Cancer; 2016 Feb; 122(4):559-64. PubMed ID: 26565895
[TBL] [Abstract][Full Text] [Related]
36. Genomic characterization of primary central nervous system lymphoma.
Fukumura K; Kawazu M; Kojima S; Ueno T; Sai E; Soda M; Ueda H; Yasuda T; Yamaguchi H; Lee J; Shishido-Hara Y; Sasaki A; Shirahata M; Mishima K; Ichimura K; Mukasa A; Narita Y; Saito N; Aburatani H; Nishikawa R; Nagane M; Mano H
Acta Neuropathol; 2016 Jun; 131(6):865-75. PubMed ID: 26757737
[TBL] [Abstract][Full Text] [Related]
37. [A case of primary testicular diffuse large B-cell lymphoma with a p53 gene point mutation].
Usami M; Kuroda H; Shimoyama S; Yoshida M; Yamada M; Abe T; Sakurai T; Fujii S; Maeda M; Wakabayashi Y; Tsukamoto K; Fujita M; Kanari Y; Takada K; Kato J
Gan To Kagaku Ryoho; 2015 May; 42(5):613-6. PubMed ID: 25981657
[TBL] [Abstract][Full Text] [Related]
38. Primary diffuse large B-cell lymphomas of central nervous system exhibit remarkably high prevalence of oncogenic MYD88 and CD79B mutations.
Yamada S; Ishida Y; Matsuno A; Yamazaki K
Leuk Lymphoma; 2015 Jul; 56(7):2141-5. PubMed ID: 25347427
[TBL] [Abstract][Full Text] [Related]
39. Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL.
Klanova M; Sehn LH; Bence-Bruckler I; Cavallo F; Jin J; Martelli M; Stewart D; Vitolo U; Zaja F; Zhang Q; Mattiello F; Sellam G; Punnoose EA; Szafer-Glusman E; Bolen CR; Oestergaard MZ; Fingerle-Rowson GR; Nielsen T; Trneny M
Blood; 2019 Feb; 133(9):919-926. PubMed ID: 30617197
[TBL] [Abstract][Full Text] [Related]
40. PD1 and PDL1 expression in primary central nervous system diffuse large B-cell lymphoma are frequent and expression of PD1 predicts poor survival.
Four M; Cacheux V; Tempier A; Platero D; Fabbro M; Marin G; Leventoux N; Rigau V; Costes-Martineau V; Szablewski V
Hematol Oncol; 2017 Dec; 35(4):487-496. PubMed ID: 27966264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
